Pharmaceuticals to Nutraceuticals: A Shift in Disease Prevention – Dilip Ghosh & R. B. Smarta

You are currently accessing the institutional-grade blueprint for <b>Pharmaceuticals to Nutraceuticals: A Shift in Disease Prevention – Dilip Ghosh & R. B. Smarta</b>. Instant digital deployment and lifetime encrypted access are guaranteed immediately upon transaction clearance.

Recently, there has been a fundamental shift in the global health and wellness industry from disease treatment to preventing chronic diseases. The use of nutraceuticals and functional foods in prevention efforts could lead to a decreased dependency on drugs. The pharmaceutical industry recognizes this shift; however, serious concerns have arisen regarding the claimed efficacy, quality, and safety of products used as medical foods.

This book examines the consumer and industry mindshift, including the scientific evidence of these foods as effective adjuncts to pharmacotherapy during all stages of treatment of various diseases, thus indicating that pharmaceuticals and nutraceuticals can and should coexist. It details quality, safety, and efficacy of foods, drugs, and nutrients; marketing and product positioning; regulatory perspectives; biomarkers and metabolites; probiotics; food/drug interactions; and future industry trends. In addition, food bioactives represent diet-based molecules that perform physiological roles related to disease prevention and treatment. As such, a considerable overlap exists between food bioactives and drugs—this book presents the case for comparing and contrasting foods versus drugs in several models of health and disease.

Get Pharmaceuticals to Nutraceuticals:  A Shift in Disease Prevention – Dilip Ghosh & R. B. Smarta, Only Price $47

---

Tag: Pharmaceuticals to Nutraceuticals:  A Shift in Disease Prevention – Dilip Ghosh & R. B. Smarta Review. Pharmaceuticals to Nutraceuticals:  A Shift in Disease Prevention – Dilip Ghosh & R. B. Smarta download. Pharmaceuticals to Nutraceuticals:  A Shift in Disease Prevention – Dilip Ghosh & R. B. Smarta discount.pharmaceuticals jobs cadila pharmaceuticals eskayef pharmaceuticals ltd fnf pharmaceuticals ltd

Trading foreign exchange, cryptocurrencies, and algorithmic assets on margin carries a high level of risk and may not be suitable for all investors. Past performance of any trading system or quantitative blueprint does not guarantee future results.<br><br><b>Asset Classification:</b>